Updated Effective Date: Huron Consulting Group Set to Join S&P SmallCap 600
PR Newswire•28/10/2026•17:43 ET
1
Key Highlights
- ➤Huron Consulting Group (HURN) joins S&P SmallCap 600 November 3, replacing Supernus Pharmaceuticals
- ➤S&P revises Huron’s effective index-entry date from November 2 to November 3
- ➤Indivior Pharmaceuticals’ acquisition of Supernus is expected to close soon
- ➤Supernus will remain in the index under the name Supernus Inc. and ticker SUPN
Updated Effective Date: Huron Consulting Group Set to Join S&P SmallCap 600 PR Newswire
NEW YORK, Oct. 28, 2026 /PRNewswire/ -- Huron Consulting Group Inc. (NASD: HURN) will replace Supernus Pharmaceuticals Inc. (NASD: SUPN) in the S&P SmallCap 600 before the opening of trading on Tuesday, November 3, instead of Monday, November 2. S&P SmallCap 600 constituent Indivior Pharmaceuticals Inc. (NASD: INDV) is acquiring Supernus Pharmaceuticals in a transaction expected to close soon, subject to final closing conditions. Post merger, Indivior Pharmaceuticals will assume the name Supernus Inc. and will trade under the symbol SUPN. It will remain in the S&P SmallCap 600.
Get started
Create a free account to read the full story.